iCAN is collaborating with startups to create opportunities for growth

iCAN is a cutting-edge precision cancer medicine and digital health initiative.

Startups collaborating with iCAN get unprecedented access to Finland’s rich clinical data, the opportunity to test in real-world settings, and the world-class expertise in our network.

We are looking for startups in fields such as data science, predictive analytics, AI, drug development and in vitro diagnostics to join us in our mission to improve outcomes and quality of life of cancer patients.

Don’t miss this opportunity to become part of a world-class cancer research cluster. Contact ican-partners@helsinki.fi for more info!